ASCO 2021 Press Releases

Viewing 1-7 of 7 articles

New Study Results Presented by Foundation Medicine and Collaborators at ASCO21 on Ancestry-Based Disparities in Prostate Cancer Care Underscore Importance of Equitable Access to Precision Medicine Advances

Phase 3 CheckMate -9ER Trial of Cabozantinib in Combination with nivolumab as a First-line Treatment for Patients with Advanced Renal Cell Carcinoma Shows Consistent Efficacy Benefits Across Subgroups

Phase III VISION Study Shows 177Lu-PSMA-617 Significantly Improves Overall Survival and Radiographic Progression-Free Survival for Men with Metastatic Castration-Resistant Prostate Cancer

Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier - The VANDAAM and SAKK 09/10 Studies

Updated Results from Two Trials of Enfortumab Vedotin-ejfv in Patients with Locally Advanced or Metastatic Urothelial Cancer Not Eligible for Cisplatin Chemotherapy

Increased PSA Screening Linked to Lower Risk of Advanced Prostate Cancer at Diagnosis and Death From the Disease in Younger African American Patients

Patients With Newly Diagnosed Cancer Live Longer in States With Higher Medicaid Income Limits